Delivery Order SPE2DB22D9311-SPE2DB25FP6ZY

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $21,878.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform this work at its Park Ridge facility and deliver the vaccine products to support the Defense Department's pharmaceutical supply requirements.

This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 through November 2026. As a crucial pharmaceutical supplier to the federal healthcare system, DMS Pharmaceutical Group leverages this master contract vehicle to provide military health facilities with an extensive portfolio of pharmaceuticals, biologics, and medical consumables on a firm fixed-price basis. The company's established position as a woman-owned small business enables it to compete effectively within federal procurement markets while maintaining consistent delivery of critical medical supplies to Department of Defense healthcare sites worldwide.